News
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...
The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced it will be phasing out the current requirements for animal testing in ...
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...
NON-ANIMAL TESTING ALSO BENEFITS HUMANS, ACCORDING TO THE CDC, MORE THAN 90% OF HUMAN DRUGS FAIL IN CLINICAL TRIALS, DESPITE SUCCESSFUL ANIMAL TRIALS. THAT’S BECAUSE OF DIFFERENCES BETWEEN ...
To get FDA approval, scientists must be able to demonstrate that a new drug or treatment is safe and effective. And currently, before they can test a new therapy in humans, they must show proof ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results